Inhibrx Biosciences Inc【INBX】株式ニュース | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Inhibrx Biosciences Inc (INBX)
Inhibrx Biosciences Inc (INBX) ニュース

Inhibrx Biosciences Inc (INBX)

14.12

-0.20

(-1.40%)

終了 3月29日 5:00AM

14.18

0.06

(0.42%)

取引時間後: 8:59AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results PR Newswire SAN DIEGO, March 17, 2025...

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the...

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance PR Newswire SAN DIEGO, Jan. 13, 2025 SAN...

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN...

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN...

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form POSASR - Post-effective Amendment to an automatic shelf registration statement

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Monksdream

Monksdream 5月前

Monksdream

Monksdream 6月前

Monksdream

Monksdream 7月前

Monksdream

Monksdream 12月前

TrendTrade2016

TrendTrade2016 2年前

heres the dolla...boom!!

TrendTrade2016

TrendTrade2016 2年前

INBX DOLLA RUMMER IN PROCESS

TrendTrade2016

TrendTrade2016 2年前

INBX...PRE MARKET VOL

Jaydixson1

Jaydixson1 2年前

Seems to be dropping

make it happen

make it happen 2年前

Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

Profitability
Profit Margin 0.00%
Operating Margin -1,448.76%

Management Effectiveness
Return on Assets -37.98%
Return on Equity -562.25%

Income Statement
Revenue 7.03M
Revenue Per Share 0.18
Quarterly Revenue Growth (yoy) -25.50%
Gross Profit -64.21M
EBITDA -100.6M
Net Income Avi to Common -110.75M
Diluted EPS -2.44

Balance Sheet
Total Debt 175.7M
Book Value Per Share -0.13

Cash Flow Statement
Operating Cash Flow -90.16M
Levered Free Cash Flow -46.31M

Inhibrx Biosciences

MYT Netherlands Parent BV

Surge Components (PK)

First Graphene (QB)

Redhill Biopharma

First Trust Alternative ...

Carbon Utility Token

Hong Kong Economic Times (PK)

SOSiLA Logistics REIT (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約